Sun, Aug 18 12:49am

Compare ENTA



Enanta Pharmaceuticals Inc [ENTA]
$71.93 1.59 (2.26%)

ENTA Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 1.42 Billion
ENTA Description

Enanta Pharmaceuticals Inc is an American biotechnology company focused on research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of the company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.


Visit Website

ENTA Earnings

EPS 0.36 P/E Ratio 19.40
Previous Earnings Tue, May 7, 2019
Latest Earnings Tue, Aug 6, 2019 (12 days ago) +5.33%

ENTA Dividend

Yield --
Ex-Date --
Pay Date --
History --

ENTA Charts

$64.09
1 Year
$105.69
Dec 24, 2018
Mar 1, 2019



Symbol Price Day % YTD %
ENTA $71.93 2.26% -0.59%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy